Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02333617 · ClinicalTrials.gov registry record · NA
Manual Therapy to Treat Gluteus Medius Trigger Points
A NA study, sponsored by Mitchell Selhorst.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02333617 is a NA study that was terminated before completion, run by Mitchell Selhorst. The registered enrollment target is 3 participants.
The verdict
NCT02333617, a NA study, was terminated before completion, sponsored by Mitchell Selhorst.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a blinded randomized controlled trial to assess the effectiveness of manual therapy to improve hip abduction strength in patients with acute anterior knee pain. The primary objective of this study is to see if manual therapy to the gluteus medius can significantly alter within-session measurements of hip abductor strength in patients with anterior knee pain. The secondary objective of this study is to see if manual therapy to the gluteus medius can significantly alter within session pain in patients with anterior knee pain.
Interventions
- OTHER Placebo Control
- OTHER Dry Needling
- OTHER Soft Tissue Mobilization
- OTHER Hip and core strengthening exercises
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02333617
The ClinicalTrials.gov registry entry for NCT02333617 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mitchell Selhorst, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo Control is the first listed.
NCT02333617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02333617 about?
NCT02333617 is a clinical study titled "Manual Therapy to Treat Gluteus Medius Trigger Points". This is a blinded randomized controlled trial to assess the effectiveness of manual therapy to improve hip abduction strength in patients with acute anterior knee pain. The primary objective of this study is to see if manual therapy to the gluteus medius can significantly alter within-session measu...
What is the current status of trial NCT02333617?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2015-01. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02333617?
The interventions under investigation include: Placebo Control (OTHER), Dry Needling (OTHER), Soft Tissue Mobilization (OTHER), Hip and core strengthening exercises (OTHER).
Who is sponsoring clinical trial NCT02333617?
This trial is sponsored by Mitchell Selhorst, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.